News
XS-Innovations wins Venture Challenge Fall 2023!
The winner of the Venture Challenge was announced today at the Dutch Life Sciences Conference. The proud winner of the 2023 fall edition is
€1.4 million for the acceleration of VivArt-X research
Venture Challenge alumnus VivArt-X will collaborate with Smart BioMaterials Consortium (SBMC) and
Venture Challenge Spring 2023 winner Exculture has successfully secured €350,000 in financing from UNIIQ/Delft Enterprises.
ExCulture is working on the development of a fermentation process that has the potential to provide a safer way of producing heparin on a larger scale.
Sirius Medical Ranked Most Innovative Dutch Healthcare SME by the Chamber of Commerce
Eindhoven, Netherlands – December 1, 2023 – Venture Challenge alumnus Sirius Medical, a leader in Surgical Marker Navigation, has been recognized as the most innovative Healthcare SME in The Netherlands, according to the prestigious Chamber
VivArt-X raises 660k€ pre-seed round
Venture Challenge alumnus VivArt-X has closed a pre-seed round of €660,000 to accelerate and further develop a proof-of-concept.
These are the Venture Challenge Fall 2023 teams!
Six teams have started the Venture Challenge Fall 2023! Between 11 October and 7 December these starting lifesciences entrepreneurs will learn everything there is to know about building and pitching a businessplan.
Scope Biosciences raises 500k€ investment from SHIFT and Oost NL
WAGENINGEN, October 23rd 2023 – Scope Biosciences B.V., a pioneer in CRISPR-Cas based molecular diagnostics and Venture Challenge Alumnus of 2020, announces a €500K investment round led by SHIFT Invest’s TTT fund and Oost NL.
Sencilia B.V. announces successful funding (€321k) of project 'Smartinfuus'
Venture Challenge alumnus (2023) Sencilia B.V. announced the successful funding of project 'SmartInfuus' in collaboration with the UMCG, University of Groningen, and Medical Innovation Xccelerator™ (MIX).
IMcoMET takes home Next Frontier Award from Erasmus Enterprise
Venture Challenge alumnus (2019) IMcoMET, a company that develops a technology to improve skin cancer diagnostics, has been honored with the Next Frontier Award from
Praxa Sense secures investment round: Certified remote patient monitoring within reach
Delft, July 2023 – The Dutch MedTech startup Praxa Sense, a company with leading solutions in remote patient monitoring, successfully secured an investment round to enter the commercialisation phase. This round is led by busin